PT2061458E - Composições de topiramato e métodos para a sua utilização - Google Patents
Composições de topiramato e métodos para a sua utilização Download PDFInfo
- Publication number
- PT2061458E PT2061458E PT07842475T PT07842475T PT2061458E PT 2061458 E PT2061458 E PT 2061458E PT 07842475 T PT07842475 T PT 07842475T PT 07842475 T PT07842475 T PT 07842475T PT 2061458 E PT2061458 E PT 2061458E
- Authority
- PT
- Portugal
- Prior art keywords
- methods
- topiramate compositions
- topiramate
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84487506P | 2006-09-15 | 2006-09-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2061458E true PT2061458E (pt) | 2015-03-11 |
Family
ID=38682330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT07842475T PT2061458E (pt) | 2006-09-15 | 2007-09-14 | Composições de topiramato e métodos para a sua utilização |
Country Status (8)
Country | Link |
---|---|
US (1) | US20080194519A1 (pt) |
EP (1) | EP2061458B1 (pt) |
DK (1) | DK2061458T3 (pt) |
ES (1) | ES2532084T3 (pt) |
PL (1) | PL2061458T3 (pt) |
PT (1) | PT2061458E (pt) |
SI (1) | SI2061458T1 (pt) |
WO (1) | WO2008034040A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090239942A1 (en) * | 2006-09-15 | 2009-09-24 | Cloyd James C | Topiramate Compositions and Methods of Making and Using the Same |
EP2150248A4 (en) * | 2007-01-16 | 2011-06-29 | Univ Johns Hopkins | GLUTAMATE RECEPTOR ANTAGONISTS AND METHODS OF USE |
US7635773B2 (en) | 2008-04-28 | 2009-12-22 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions |
LT3391890T (lt) * | 2010-06-29 | 2021-11-10 | Merck Sharp & Dohme Corp. | Posakonazolo intraveninio tirpalo kompozicijos, stabilizuotos pakeistu beta-ciklodekstrinu |
DK2814849T3 (da) | 2012-02-15 | 2020-03-09 | Cydex Pharmaceuticals Inc | Fremgangsmåde til fremstilling af cyclodextrin-derivater |
JP2015508846A (ja) | 2012-02-28 | 2015-03-23 | サイデックス・ファーマシューティカルズ・インコーポレイテッド | アルキル化シクロデキストリン組成物ならびにその調製方法および使用方法 |
SG11201503089WA (en) | 2012-10-22 | 2015-05-28 | Cydex Pharmaceuticals Inc | Alkylated cyclodextrin compositions and processes for preparing and using the same |
HUE063851T2 (hu) | 2014-08-22 | 2024-02-28 | Cydex Pharmaceuticals Inc | Frakcionált alkilezett ciklodextrin készítmények és eljárás ezek elõállítására és alkalmazására |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
KR0166088B1 (ko) * | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
US5258402A (en) * | 1992-06-11 | 1993-11-02 | Mcneil-Ppc, Inc. | Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates |
US5998380A (en) * | 1995-10-13 | 1999-12-07 | New England Medical Center Hospitals, Inc. | Treatment of migraine |
US5952187A (en) * | 1995-12-01 | 1999-09-14 | Oxis International, Inc. | Topiramate immunoassay |
US6046177A (en) * | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
US5874418A (en) * | 1997-05-05 | 1999-02-23 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use |
DE69819721T2 (de) * | 1997-06-13 | 2004-09-23 | Cydex Inc., Overland Park | Zusammensetzung mit erhöhter lagerstabilität enthaltend cyclodextrin und wirkstoffe oder wirkstoff-vorstufen, die in wasserunlösliche komponenten zersetzt werden |
UA65607C2 (uk) * | 1998-03-04 | 2004-04-15 | Орто-Макнейл Фармацевтикал, Інк. | Фармацевтична композиція (варіанти) та спосіб її приготування |
US6541520B1 (en) * | 1998-08-05 | 2003-04-01 | Brookhaven Science Associates | Treatment of addiction and addiction-related behavior |
US7034013B2 (en) * | 2001-03-20 | 2006-04-25 | Cydex, Inc. | Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
WO2003011271A2 (en) * | 2001-08-03 | 2003-02-13 | Children's Medical Center Corporation | Methods and compositions for modulating brain damage |
US6559293B1 (en) * | 2002-02-15 | 2003-05-06 | Transform Pharmaceuticals, Inc. | Topiramate sodium trihydrate |
US6869939B2 (en) * | 2002-05-04 | 2005-03-22 | Cydex, Inc. | Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
US20030235576A1 (en) * | 2002-06-15 | 2003-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New drug combinations for the treatment of ischaemic conditions |
US6949518B1 (en) * | 2003-06-25 | 2005-09-27 | Pao-Hsien Chu | Methods for treating macular degeneration with topiramate |
EP1706098A4 (en) * | 2003-11-26 | 2012-08-15 | Supernus Pharmaceuticals Inc | MICELLAR SYSTEMS SUITABLE FOR THE DELIVERY OF LIPOPHILIC OR HYDROPHOBIC COMPOUNDS |
EP1771159A4 (en) * | 2004-07-22 | 2009-04-29 | Amorepacific Corp | SLOW RELEASE PREPARATIONS CONTAINING TOPIRAMATE AND PROCESS FOR PRODUCING THE SAME |
-
2007
- 2007-09-14 DK DK07842475.1T patent/DK2061458T3/en active
- 2007-09-14 SI SI200731615T patent/SI2061458T1/sl unknown
- 2007-09-14 ES ES07842475.1T patent/ES2532084T3/es active Active
- 2007-09-14 PL PL07842475T patent/PL2061458T3/pl unknown
- 2007-09-14 US US11/855,642 patent/US20080194519A1/en not_active Abandoned
- 2007-09-14 WO PCT/US2007/078465 patent/WO2008034040A1/en active Application Filing
- 2007-09-14 PT PT07842475T patent/PT2061458E/pt unknown
- 2007-09-14 EP EP07842475.1A patent/EP2061458B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2061458B1 (en) | 2014-12-10 |
EP2061458A1 (en) | 2009-05-27 |
SI2061458T1 (sl) | 2015-04-30 |
PL2061458T3 (pl) | 2015-07-31 |
ES2532084T3 (es) | 2015-03-24 |
US20080194519A1 (en) | 2008-08-14 |
WO2008034040A1 (en) | 2008-03-20 |
DK2061458T3 (en) | 2015-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2035014A4 (en) | FUCOIDANE PREPARATIONS AND METHODS | |
IL195619A0 (en) | Compositions and methods for joininig non-conjoined iumens | |
ZA201001300B (en) | Antigen-asjuvant compositions and methods | |
HK1137670A1 (en) | Compositions and methods for arthrodetic procedures | |
TWI561237B (en) | Substituted dihydropyrazolones and their use | |
EP2101731A4 (en) | PROCESSES AND COMPOSITIONS WITH END OXIFES | |
EP2086318A4 (en) | NEUROPROTEKTIVE COMPOSITIONS AND METHOD | |
EP2046936A4 (en) | BIOCIDAL COMPOSITIONS AND METHODS | |
EP2043696A4 (en) | METHOD AND COMPOSITIONS FOR GC1QR / P32 TARGETING | |
EP2037743A4 (en) | PIG COMPOSITIONS AND RELATED PROCEDURES | |
IL247957A0 (en) | Anti-ephrinb2 antibodies and methods of using them | |
EP2066174A4 (en) | COMPOSITIONS WITH ALPHA-1-ANTITRYPINE AND METHOD OF USE THEREOF | |
GB0611115D0 (en) | Compounds and their use | |
EP2152247A4 (en) | COMPOSITIONS AND METHODS ANTI-INSOMNIA | |
GB0721291D0 (en) | Methods and compositions | |
EP2088865A4 (en) | METHODS AND COMPOSITIONS AROUND GUGGULPHOSPHOLIPIDS | |
GB0617171D0 (en) | Novel compositions and methods | |
IL205248A0 (en) | Compositions and methods for making androstenediones | |
PL2061458T3 (pl) | Kompozycje topiramatu i sposoby ich stosowania | |
GB0719526D0 (en) | Compositions and methods | |
GB0614365D0 (en) | Pharmaceutical compositions and their use | |
PL2132251T3 (pl) | Kompozycja i sposób | |
EP1998753A4 (en) | COMPOSITIONS FOR MAJOR DEPOSITION AND USES THEREOF | |
GB0620930D0 (en) | Composition and method for use thereof | |
GB0625208D0 (en) | Composition and method |